ArticleBMJ open2026

Feasibility of a phase 3 partially randomised clinical trial to assess the safety and efficacy of paediatric praziquantel for schistosomiasis treatment in children aged 3 months to 6 years in endemic regions of Brazil: a pilot study.

Camilla Almeida Menezes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.